SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 25th, 2019 • Midatech Pharma PLC • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”), dated as of October 22, 2019, is between Midatech Pharma PLC, a public limited company organized under the laws of England and Wales (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES midatech pharma plcSecurity Agreement • October 25th, 2019 • Midatech Pharma PLC • Pharmaceutical preparations
THIS WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the earlier of (x) a time when there is an effective registration statement to cover the issuance of the Warrant ADSs, and such Warrant ADSs or Warrant Shares may be issued free of all legends, each as evidenced by an opinion of counsel reasonably satisfactory to the Depositary delivered to the Depositary, or (y) the entry into a restricted issuance agreement (the “Restricted Issuance Agreement”) by and among the Company , the Depositary and all holders and beneficial owners of restricted American Depositary Shares evidenced by restricted American Depositary Receipts to be issued thereunder, which such Restricted Issuance Agreement shall be in form and substance satisfactory
